Berneman ZN - Search Results

1

Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma.

Roex G, Timmers M, Wouters K, Campillo-Davo D, Flumens D, Schroyens W, Chu Y, Berneman ZN, Lion E, Luo F, Anguille S. Roex G, et al. Among authors: berneman zn. J Hematol Oncol. 2020 Dec 3;13(1):164. doi: 10.1186/s13045-020-01001-1. J Hematol Oncol. 2020. PMID: 33272302 Free PMC article.

2

Clinical use of dendritic cells for cancer therapy.

Anguille S, Smits EL, Lion E, van Tendeloo VF, Berneman ZN. Anguille S, et al. Among authors: berneman zn. Lancet Oncol. 2014 Jun;15(7):e257-67. doi: 10.1016/S1470-2045(13)70585-0. Lancet Oncol. 2014. PMID: 24872109 Review.

3

Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen.

Timmers M, Roex G, Wang Y, Campillo-Davo D, Van Tendeloo VFI, Chu Y, Berneman ZN, Luo F, Van Acker HH, Anguille S. Timmers M, et al. Among authors: berneman zn. Front Immunol. 2019 Jul 16;10:1613. doi: 10.3389/fimmu.2019.01613. eCollection 2019. Front Immunol. 2019. PMID: 31379824 Free PMC article. Review.

4

Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells.

Roex G, Campillo-Davo D, Flumens D, Shaw PAG, Krekelbergh L, De Reu H, Berneman ZN, Lion E, Anguille S. Roex G, et al. Among authors: berneman zn. J Transl Med. 2022 Mar 14;20(1):124. doi: 10.1186/s12967-022-03326-6. J Transl Med. 2022. PMID: 35287669 Free PMC article.

5

Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answers.

Anguille S, Lion E, Smits E, Berneman ZN, van Tendeloo VF. Anguille S, et al. Among authors: berneman zn. Hum Vaccin. 2011 May;7(5):579-84. doi: 10.4161/hv.7.5.14652. Epub 2011 May 1. Hum Vaccin. 2011. PMID: 21422813

6

Dendritic cell vaccination in acute myeloid leukemia.

Anguille S, Willemen Y, Lion E, Smits EL, Berneman ZN. Anguille S, et al. Among authors: berneman zn. Cytotherapy. 2012 Jul;14(6):647-56. doi: 10.3109/14653249.2012.693744. Cytotherapy. 2012. PMID: 22686130 Review.

7

Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells.

Van Acker HH, Anguille S, Willemen Y, Van den Bergh JM, Berneman ZN, Lion E, Smits EL, Van Tendeloo VF. Van Acker HH, et al. Among authors: berneman zn. J Hematol Oncol. 2016 Sep 29;9(1):101. doi: 10.1186/s13045-016-0329-3. J Hematol Oncol. 2016. PMID: 27686372 Free PMC article.

8

Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions.

Granacher NCP, Berneman ZN, Schroyens W, Van de Velde ALR, Verlinden A, Gadisseur APA. Granacher NCP, et al. Among authors: berneman zn. Exp Hematol Oncol. 2017 Apr 11;6:9. doi: 10.1186/s40164-017-0071-8. eCollection 2017. Exp Hematol Oncol. 2017. PMID: 28401025 Free PMC article.

9

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing.

Campillo-Davo D, Fujiki F, Van den Bergh JMJ, De Reu H, Smits ELJM, Goossens H, Sugiyama H, Lion E, Berneman ZN, Van Tendeloo V. Campillo-Davo D, et al. Among authors: berneman zn. Front Immunol. 2018 Nov 7;9:2503. doi: 10.3389/fimmu.2018.02503. eCollection 2018. Front Immunol. 2018. PMID: 30464762 Free PMC article.

10

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy.

Campillo-Davo D, De Laere M, Roex G, Versteven M, Flumens D, Berneman ZN, Van Tendeloo VFI, Anguille S, Lion E. Campillo-Davo D, et al. Among authors: berneman zn. Pharmaceutics. 2021 Mar 16;13(3):396. doi: 10.3390/pharmaceutics13030396. Pharmaceutics. 2021. PMID: 33809779 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

336 results

Search Page